PFS
SGMO

Prospera Financial Services’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Prospera Financial Services’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-200
Closed -$1K – 2440
2022
Q1 		$1K Buy
+200
New +$1.19K ﹤0.01% 2662

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Prospera Financial Services's SGMO Position: Q2 2022 in Review

Prospera Financial Services sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2022, closing a stake of 200 shares — an estimated $1K sold.

Prospera Financial Services first reported a position in SGMO in Q1 2022 and held it in 1 quarter. The position peaked at $1K in Q1 2022. 188 funds tracked by Wall St. Rank hold SGMO as of Q2 2022.

  • Prospera Financial Services reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2022 after selling out during the quarter.
  • Prospera Financial Services sold 200 SANGAMO THERAPEUTICS INC shares in Q2 2022, an estimated $1K.
  • Prospera Financial Services first reported a position in SANGAMO THERAPEUTICS INC in Q1 2022 and held it in 1 quarter.
  • Prospera Financial Services's SANGAMO THERAPEUTICS INC position peaked at $1K in Q1 2022.
  • 188 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2022.

Based on Prospera Financial Services's 13F filing for Q2 2022, filed 8 Aug 2022.